| 证券代码 | AMAG.O |
| 证券名称 | AMAG Pharmaceutical Inc |
| 证券类型 | 美股 |
| 上市场所 | 纳斯达克交易所 |
| 上市板块 | - |
| 发行方式 | - |
| 首发上市日 | 2006-06-27 |
| 首发价格(元) | - |
| 首发数量(股) | 0 |
| 首发募资额(元) | - |
| 首发主承销商 | - |
| 货币单位 | USD |
| 公司名称 | AMAG Pharmaceuticals, Inc. |
| 注册地址 | 美国特拉华州 |
| 办公地址 | 1100 Winter Street, Waltham, Massachusetts, USA |
| 成立日期 | 1981 |
| 董事会主席 | Gino Santini |
| 公司属地 | United States 美国 |
| 公司网址 | www.amagpharma.com |
| 电话 | +1 (617) 498-3300 |
| 传真 | +1 (617) 649-1654 |
| 公司简介 | AMAG Pharmaceuticals, Inc. is a pharmaceutical company focused on bringing innovative products to patients with unmet medical needs. They do this by leveraging their development and commercial expertise to invest in and grow their pharmaceutical products across a range of therapeutic areas, including women’s health. In addition, they seek to collaborate on and acquire promising therapies at various stages of development, and advance them through the clinical and regulatory process to deliver new treatment options to patients. |